News
Later this month, the Food and Drug Administration is widely expected to approve a groundbreaking twice-yearly injection to ...
FA new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month.
A Houston physician has sued the federal government to cut benefits through the Affordable Care Act that requires access to ...
Of 49 countries surveyed in a recent analysis, 15 have historically relied on the the U.S. for most of the funding for their ...
The current administration has pulled millions in HIV-related grants and cut staffing positions essential to research and ...
As politicians, activists and researchers duke it out from labs and clinics and press conferences, those who have the most to ...
A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration later this month.
Gilead's HIV drug lenacapavir earns FDA priority review after strong trial results, with the company planning to double U.S.
As politicians, activists and researchers duke it out from labs and clinics and press conferences, those who have the most to ...
In Philippi village in the Western Cape of South Africa, 24-year-old Simamkele Matinise works at an HIV-prevention mobile ...
2d
HealthDay on MSNInitiation of HIV PrEP in Young Adults Rose in Recent YearsNina E. Hill, MD, from the University of Michigan in Ann Arbor, and colleagues examined recent trends in HIV PrEP among young adults (aged 18 to 25 years). The analysis included data from the IQVIA ...
Lenacapavir works to both treat and prevent HIV, making it a promising drug should it be approved by the FDA later this month.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results